APA (7th ed.) Citation

L, X., R, M., M, P., MS, R., KQ, C., T, T., . . . TJ, S. (2026). Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches. Antibody therapeutics, 9(3), 215. https://doi.org/10.1093/abt/tbag005

Chicago Style (17th ed.) Citation

L, Xin, Mahadik R, Prorok M, Rodriguez MS, Chan KQ, Tolbert T, Li Y, and Siahaan TJ. "Preventing Physical and Chemical Degradation of the LABL-Fc-MOGR5, a Bifunctional Peptide Inhibitor, with Formulation Development Approaches." Antibody Therapeutics 9, no. 3 (2026): 215. https://doi.org/10.1093/abt/tbag005.

MLA (9th ed.) Citation

L, Xin, et al. "Preventing Physical and Chemical Degradation of the LABL-Fc-MOGR5, a Bifunctional Peptide Inhibitor, with Formulation Development Approaches." Antibody Therapeutics, vol. 9, no. 3, 2026, p. 215, https://doi.org/10.1093/abt/tbag005.